- Home
- CPHI vs CHNR Comparison
CPHI vs CHNR Comparison
Compare CPHI & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- CHNR
- Stock Information
- Founded
- CPHI N/A
- CHNR N/A
- Country
- CPHI China
- CHNR Hong Kong
- Employees
- CPHI N/A
- CHNR N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- CPHI Health Care
- CHNR Basic Materials
- Exchange
- CPHI Nasdaq
- CHNR Nasdaq
- Market Cap
- CPHI 5.4M
- CHNR 5.2M
- IPO Year
- CPHI N/A
- CHNR 1995
- Fundamental
- Price
- CPHI $2.22
- CHNR $0.56
- Analyst Decision
- CPHI
- CHNR
- Analyst Count
- CPHI 0
- CHNR 0
- Target Price
- CPHI N/A
- CHNR N/A
- AVG Volume (30 Days)
- CPHI 85.3K
- CHNR 50.3K
- Earning Date
- CPHI 05-23-2025
- CHNR 05-15-2025
- Dividend Yield
- CPHI N/A
- CHNR N/A
- EPS Growth
- CPHI N/A
- CHNR N/A
- EPS
- CPHI N/A
- CHNR N/A
- Revenue
- CPHI $4,295,377.00
- CHNR N/A
- Revenue This Year
- CPHI N/A
- CHNR N/A
- Revenue Next Year
- CPHI N/A
- CHNR N/A
- P/E Ratio
- CPHI N/A
- CHNR N/A
- Revenue Growth
- CPHI N/A
- CHNR N/A
- 52 Week Low
- CPHI $1.20
- CHNR $0.45
- 52 Week High
- CPHI $4.10
- CHNR $1.13
- Technical
- Relative Strength Index (RSI)
- CPHI 56.97
- CHNR 52.58
- Support Level
- CPHI $2.08
- CHNR $0.51
- Resistance Level
- CPHI $2.50
- CHNR $0.66
- Average True Range (ATR)
- CPHI 0.23
- CHNR 0.05
- MACD
- CPHI 0.06
- CHNR 0.00
- Stochastic Oscillator
- CPHI 63.64
- CHNR 35.87
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.